Neuro-Sjögren: Peripheral Neuropathy With Limb Weakness in Sjögren's Syndrome

Tabea Seeliger, Nils K Prenzler, Stefan Gingele, Benjamin Seeliger, Sonja Körner, Thea Thiele, Lena Bönig, Kurt-Wolfram Sühs, Torsten Witte, Martin Stangel, Thomas Skripuletz, Tabea Seeliger, Nils K Prenzler, Stefan Gingele, Benjamin Seeliger, Sonja Körner, Thea Thiele, Lena Bönig, Kurt-Wolfram Sühs, Torsten Witte, Martin Stangel, Thomas Skripuletz

Abstract

Objective: Sjögren's syndrome is a heterogeneous inflammatory disorder frequently involving peripheral nerves with a wide spectrum of sensory modalities and distribution patterns. The objective of this cross-sectional study was to determine characteristics of Sjögren's syndrome as a cause for severe neuropathy with limb weakness. Methods: One hundred and eighty four patients with polyneuropathy associated with limb weakness underwent routine diagnostics including investigations for Sjögren's syndrome. Forty-four patients with Sjögren's syndrome (ACR-EULAR classification criteria) and severe neuropathy were identified. Results: Sjögren's syndrome was found at a median age of 63 years and the gender distribution showed a balanced female-male ratio of 1:1. Anti-SSA(Ro) antibodies were detected in 48% while seronegative patients were diagnosed with Sjögren's syndrome based on sialadenitis on minor salivary gland biopsy with a focus score ≥1. The majority of patients (93%) were diagnosed with Sjögren's syndrome after neurological symptoms appeared. Limbs were symmetrically involved in 84% of patients (57% tetraparesis, 27% paraparesis). Sensory function was not affected in 11% of patients indicating that Sjögren's syndrome associated neuropathy can present as a pure motor syndrome. Electrophysiological measurements did not reveal pathognomonic findings (23% demyelinating pattern, 36% axonal pattern, 41% both demyelinating and axonal damage signs). More than half of our patients fulfilled the European Federation of Neurological Societies (EFNS) diagnostic criteria for CIDP indicating that distinction between Neuro-Sjögren and other causes of neuropathy such as CIDP is challenging. Interpretation: Our findings show that severe neuropathy with limb weakness is often associated with Sjögren's syndrome. This is of great importance in identifying and understanding the causes of immune mediated polyneuropathy.

Keywords: Neuro-Sjögren; Sjögren's syndrome; chronic inflammatory demyelinating polyneuropathy; motoneuron disease; neuropathy.

Figures

Figure 1
Figure 1
Diagnostic approach for evaluation of Sjögren's syndrome in patients with polyneuropathy.
Figure 2
Figure 2
(A) Neuropathy diagnoses prior to Sjögren's syndrome diagnosis. (B) Distribution of electrophysiological damage pattern at initial neurographic analysis.
Figure 3
Figure 3
Distribution of cerebrospinal fluid (CSF) parameters in all study patients: (A) CSF cell counts, (B) CSF total protein, and (C) albumin quotient (CSF albumin/serum albumin × 103). Horizontal bars indicate median values.

References

    1. Sjögren H. Zur kenntnis der keratoconjunctivitis sicca. Acta Ophthalmol. (1933) 13:1–39. 10.1111/j.1755-3768.1935.tb04186.x
    1. Fox RI. Sjögren' s syndrome. Lancet. (2004) 321–31. 10.1016/S0140-6736(05)66990-5
    1. Mori K, Iijima M, Koike H, Hattori N, Tanaka F, Watanabe H, et al. . The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain. (2005) 128:2518–34. 10.1093/brain/awh605
    1. Pars K, Pul R, Schwenkenbecher P, Sühs K-W, Wurster U, Witte T, et al. . Cerebrospinal fluid findings in neurological diseases associated with Sjögren's syndrome. Eur Neurol. (2017) 77:91–102. 10.1159/000454765
    1. Garza-Alpirez A, Arana-Guajardo AC, Esquivel-Valerio JA, Villarreal-Alarcón MA, Galarza-Delgado DA. Hypokalemic paralysis due to primary Sjögren syndrome: case report and review of the literature. Case Rep Rheumatol. (2017) 2017:7509238. 10.1155/2017/7509238
    1. Lin Y-K, Yang F-C, Liu F-C, Lee J-T, Sung Y-F. Co-occurrence of guillain-barre syndrome and primary sjogren syndrome in an elderly woman. Acta Neurol Taiwan. (2016) 25:83–87. Available online at:
    1. Horai Y, Nishino A, Nakashima Y, Suzuki T, Okada A, Kawashiri S-Y, et al. . A case of Sjögren's syndrome presenting as trigeminal nerve palsy. JPN J Clin Immunol. (2012) 35:199–202. 10.2177/jsci.35.199
    1. Vernant J-C, Buisson G, Magdeleine J, De Thore J, Jouannelle A, Neisson-Vernant C, et al. T-lymphocyte alveolitis, tropical spastic paresis, and sjögren syndrome. Lancet. (1988) 331:177 10.1016/S0140-6736(88)92744-4
    1. Pereira PR, Viala K, Maisonobe T, Haroche J, Mathian A, Hié M, et al. . Sjögren sensory neuronopathy (Sjögren Ganglionopathy): long-term outcome and treatment response in a series of 13 cases. Medicine. (2016) 95:e3632. 10.1097/MD.0000000000003632
    1. Gemignani F, Marbini A, Pavesi G, Di Vittorio S, Manganelli P, Cenacchi G, et al. . Peripheral neuropathy associated with primary Sjogren's syndrome. Neurol Neurosurg Psychiatry. (1994) 57:983–6. 10.1136/jnnp.57.8.983
    1. Merkies ISJ, Schmitz PIM, van der Meché FGA, Samijn JPA, van Doorn PA. Inflammatory Neuropathy Cause and Treatment (INCAT) group. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry. (2002) 72:596–601. 10.1136/jnnp.72.5.596
    1. Merkies ISJ, Schmitz PIM. Getting closer to patients: the INCAT Overall Disability Sum Score relates better to patients' own clinical judgement in immune-mediated polyneuropathies. J Neurol Neurosurg Psychiatry. (2006) 77:970–2. 10.1136/jnnp.2005.076174
    1. Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. . 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome. Ann Rheum Dis. (2017) 76:9–16. 10.1136/annrheumdis-2016-210571
    1. Daniels TE, Cox D, Shiboski CH, Schiødt M, Wu A, Lanfranchi H, et al. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's Syndrome (SS) among 1726 registry participants NIH Public Access. Arthritis Rheum. (2011) 63:2021–30. 10.1002/art.30381
    1. Kohler PF, Winter ME. A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test. Arthritis Rheum. (1985) 28:1128–32. 10.1002/art.1780281008
    1. Schwenkenbecher P, Sarikidi A, Wurster U, Bronzlik P, Sühs K-W, Raab P, et al. . McDonald criteria 2010 and 2005 compared: persistence of high oligoclonal band prevalence despite almost doubled diagnostic sensitivity. Int J Mol Sci. (2016) 17:1592. 10.3390/ijms17091592
    1. Reiber H. Cerebrospinal fluid–physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler. (1998) 4:99–107. 10.1177/135245859800400302
    1. Stålberg E, Falck B, Gilai A, Jabre J, Sonoo M, Todnem K. Standards for quantification of EMG and neurography. The international federation of clinical neurophysiology. Electroencephalogr Clin Neurophysiol Suppl. (1999) 52:213–20.
    1. Van den Bergh PYK, Hadden RDM, Bouche P, Cornblath DR, Hahn A, Illa I, et al. . European federation of neurological societies/peripheral nerve society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. Eur J Neurol. (2010) 17:356–63. 10.1111/j.1468-1331.2009.02930.x
    1. Paliwal VK, Rai AS, Kumar S, Verma R, Agarwal V. Proximal muscle weakness with overlying hypokalemic periodic paralysis in Sjögren syndrome. JCR J Clin Rheumatol. (2018) 1. 10.1097/RHU.0000000000000776
    1. Sène D, Jallouli M, Lefaucheur J-P, Saadoun D, Costedoat-Chalumeau N, Maisonobe T, et al. . Peripheral neuropathies associated with primary Sjögren syndrome. Medicine. (2011) 90:133–8. 10.1097/MD.0b013e31820fd2d1
    1. Scofield AK, Radfar L, Ice JA, Vista E, Anaya J-M, Houston G, et al. Relation of sensory peripheral neuropathy in Sjögren syndrome to anti-ro/SSA. J Clin Rheumatol. (2012) 18:290–3. 10.1097/RHU.0b013e3182675e4f
    1. Brito-Zerón P, Acar-Denizli N, Ng W-F, Zeher M, Rasmussen A, Mandl T, et al. How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project). Clin Exp Rheumatol. (2018) 112 (36 Suppl):102–12. Available online at:
    1. Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, del Pino-Montes J, et al. . Primary Sjögren syndrome in Spain. Medicine. (2008) 87:210–9. 10.1097/MD.0b013e318181e6af
    1. Pavlakis PP, Alexopoulos H, Kosmidis ML, Mamali I, Moutsopoulos HM, Tzioufas AG, et al. . Peripheral neuropathies in Sjögren's syndrome: a critical update on clinical features and pathogenetic mechanisms. J Autoimmun. (2012) 39:27–33. 10.1016/j.jaut.2012.01.003
    1. Delalande S, de Seze J, Fauchais A-L, Hachulla E, Stojkovic T, Ferriby D, et al. . Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine. (2004) 83:280–91. 10.1097/01.md.0000141099.53742.16
    1. Beeson PB. Age and sex associations of 40 autoimmune diseases. Am J Med. (1994) 96:457–62. 10.1016/0002-9343(94)90173-2
    1. Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA. Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982–2003. Rheumatology. (2006) 45:187–91. 10.1093/rheumatology/kei107
    1. Izmirly PM, Buyon JP, Wan I, Belmont HM, Sahl S, Salmon JE, et al. . The incidence and prevalence of adult primary Sjögren's syndrome in New York County. Arthr Care Res. (2019) 71:949–60. 10.1002/acr.23707
    1. Sivadasan A, Muthusamy K, Patel B, Benjamin RN, Prabhakar AT, Mathew V, et al. . Clinical spectrum, therapeutic outcomes, and prognostic predictors in Sjogren's syndrome-associated neuropathy. Ann Indian Acad Neurol. (2017) 20:278–83. 10.4103/aian.AIAN_116_17
    1. Carvajal Alegria G, Guellec D, Mariette X, Gottenberg J-E, Dernis E, Dubost J-J, et al. . Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort. RMD Open. (2016) 2:e000179. 10.1136/rmdopen-2015-000179
    1. Zahlane S, Louhab N, El Mellakh M, Kissani N. Anterior horn syndrome: a rare manifestation of primary Sjögren's syndrome. Jt Bone Spine. (2016) 83:448–50. 10.1016/j.jbspin.2016.02.018
    1. Lafitte C, Amoura Z, Cacoub P, Pradat-Diehl P, Picq C, Salachas F, et al. . Neurological complications of primary Sjögren's syndrome. J Neurol. (2001) 248:577–84. 10.1007/s004150170135
    1. Lozeron P, Mariani L-L, Dodet P, Beaudonnet G, Théaudin M, Adam C, et al. . Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy. Neurology. (2018) 91:e143–52. 10.1212/WNL.0000000000005777

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren